The Anti-BAFFR Ianalumab Biosimilar Monoclonal Antibody (HDBS0045) is a cutting-edge biopharmaceutical product designed for targeting B-cell activation factor receptor (BAFFR) in various research applications. This biosimilar antibody, developed through advanced technology, exhibits high specificity and binding affinity to BAFFR, making it an ideal tool for studying B-cell biology and immune responses.BAFFR is a key receptor involved in B-cell survival, differentiation, and maturation, playing a crucial role in immune system function. Dysregulation of BAFFR signaling has been linked to autoimmune diseases, B-cell lymphomas, and other immune-related disorders. By targeting BAFFR, researchers can gain valuable insights into the molecular mechanisms underlying these diseases and potentially develop novel therapeutic strategies.
This monoclonal antibody, derived from a well-characterized cell line, offers reliable performance in various experimental techniques, such as flow cytometry, immunofluorescence, and immunohistochemistry. Its high specificity and sensitivity enable precise detection and quantification of BAFFR expression in cell lines, tissues, and biological samples, facilitating in-depth investigations into B-cell biology and immunopathology.Overall, the Anti-BAFFR Ianalumab Biosimilar Monoclonal Antibody (HDBS0045) represents a valuable tool for researchers seeking to elucidate the role of BAFFR in immune regulation and disease pathogenesis. By leveraging the
Product Name:
Ianalumab (Anti-BAFFR) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0045
Target:
BAFF-R
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
VAY-736
Description:
Anti-BAFFR (ianalumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
